NASDAQ 
CRSP’s Casgevy Sees Steady Uptake Post Launch CRISPR and partner Vertex Pharmaceuticals’ VRTX...
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of the 13 Biotech Stocks with Huge Upside Potential. The company shared new data at the 48th...
Vertex Pharmaceuticals (NasdaqGS:VRTX) presented promising clinical data on their CFTR modulator...
Vertex Pharmaceuticals VRTX has outperformed the market over the past 10 years by 2.68% on an annualized basis producing an average annual return of 13.76%. Currently, Vertex Pharmaceuticals ...
OLD National Bancorp IN purchased a new position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) in the 1st quarter, according to the company in its most recent ...
Vortex Energy Corp. (CSE: VRTX) (OTC: VTECF) (FSE: AA3) (“Vortex” or the “Company”) is pleased to announce plans for a detailed geophysical survey at its flagship Robinsons River Salt Project ...
The company outlined its strategic initiatives, focusing on innovation and market expansion. While...
The Nasdaq 100 (^NDX) is home to some of the biggest success stories in tech and growth investing....
“This is already beginning to happen,” Wood said. Wood highlighted CRISPR Therapeutics AG CRSP and...
Vertex Inc. trust sells $115.35 million in stock
